CN106727857A - It is a kind of that the preparation method for preventing and treating hyperuricemia and gout medicine-food two-purpose monomer is extracted from Semen Cuscutae - Google Patents
It is a kind of that the preparation method for preventing and treating hyperuricemia and gout medicine-food two-purpose monomer is extracted from Semen Cuscutae Download PDFInfo
- Publication number
- CN106727857A CN106727857A CN201610996958.XA CN201610996958A CN106727857A CN 106727857 A CN106727857 A CN 106727857A CN 201610996958 A CN201610996958 A CN 201610996958A CN 106727857 A CN106727857 A CN 106727857A
- Authority
- CN
- China
- Prior art keywords
- semen cuscutae
- food
- preparation
- eluent
- extraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000582 semen Anatomy 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 239000000178 monomer Substances 0.000 title claims abstract description 38
- 201000001431 Hyperuricemia Diseases 0.000 title claims abstract description 28
- 201000005569 Gout Diseases 0.000 title claims abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 86
- 239000003480 eluent Substances 0.000 claims abstract description 46
- 238000000605 extraction Methods 0.000 claims abstract description 28
- 150000001875 compounds Chemical class 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 238000010992 reflux Methods 0.000 claims abstract description 20
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 13
- 230000036541 health Effects 0.000 claims abstract description 9
- 239000011347 resin Substances 0.000 claims abstract description 8
- 229920005989 resin Polymers 0.000 claims abstract description 8
- 239000002775 capsule Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims description 23
- 244000269722 Thea sinensis Species 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 239000002778 food additive Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 10
- 238000010828 elution Methods 0.000 claims description 10
- 229930182470 glycoside Natural products 0.000 claims description 10
- 238000000703 high-speed centrifugation Methods 0.000 claims description 10
- 238000001179 sorption measurement Methods 0.000 claims description 10
- 230000003068 static effect Effects 0.000 claims description 10
- 235000013373 food additive Nutrition 0.000 claims description 9
- 150000002338 glycosides Chemical class 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 6
- 229920002261 Corn starch Polymers 0.000 claims description 4
- 239000000287 crude extract Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000005292 vacuum distillation Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000001291 vacuum drying Methods 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 abstract description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract description 2
- 125000003147 glycosyl group Chemical group 0.000 abstract description 2
- 235000015091 medicinal tea Nutrition 0.000 abstract description 2
- 229930015704 phenylpropanoid Natural products 0.000 abstract description 2
- 125000001474 phenylpropanoid group Chemical group 0.000 abstract description 2
- 239000002798 polar solvent Substances 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 23
- 229940079593 drug Drugs 0.000 description 20
- 238000000034 method Methods 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 10
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 238000002791 soaking Methods 0.000 description 8
- 235000013616 tea Nutrition 0.000 description 8
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 7
- 229940116269 uric acid Drugs 0.000 description 7
- 238000012449 Kunming mouse Methods 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 5
- 210000005239 tubule Anatomy 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 230000037396 body weight Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000007666 subchronic toxicity Effects 0.000 description 3
- 231100000195 subchronic toxicity Toxicity 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 2
- 241000601164 Clematis orientalis Species 0.000 description 2
- 244000013539 Cuscuta australis Species 0.000 description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 2
- 206010062049 Lymphocytic infiltration Diseases 0.000 description 2
- 235000003805 Musa ABB Group Nutrition 0.000 description 2
- 240000008790 Musa x paradisiaca Species 0.000 description 2
- 235000015266 Plantago major Nutrition 0.000 description 2
- 235000008081 Rheum officinale Nutrition 0.000 description 2
- 240000004980 Rheum officinale Species 0.000 description 2
- 206010046337 Urate nephropathy Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000000431 campesterol Nutrition 0.000 description 2
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000031023 Amana edulis Species 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 244000036905 Benincasa cerifera Species 0.000 description 1
- 235000011274 Benincasa cerifera Nutrition 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 241000110637 Cuscuta chinensis Species 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 241001016310 Epimedium grandiflorum Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241001499733 Plantago asiatica Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 235000018905 epimedium Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000006025 fining agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000011268 leukocyte chemotaxis Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000002105 tongue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- -1 triterpene acids Chemical class 0.000 description 1
- 230000003424 uricosuric effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The preparation method for preventing and treating hyperuricemia and gout medicine-food two-purpose monomer is extracted from Semen Cuscutae the present invention relates to a kind of, after Semen Cuscutae raw material is smashed, ethanol is added to be heated to reflux carrying out coarse extraction, then purified using macroporous resin column, and test and analyze eluent with thin-layered chromatography, collect the eluent with accounting target compound high and merge, gained eluent is finally prepared into product.Semen Cuscutae of the present invention contains phenylpropanoids, and monomer of the present invention is made up of double parallel tetrahydrofuran ring connection glycosyls, and such as n-butanol, ethyl acetate dissolubility are preferable in medium polar solvent, and with certain water solubility.The present invention is decocted using 60% ethanol and extracted, and polar macroporous purifying resin, autotelic enrichment subject monomers compound group, low cost, high income easily realizes industrialization and scale.Capsule, tablet, health care medicinal tea etc. prepared by the invention, convenient to takeization, with diversification feature.
Description
Technical field
The present invention relates to a kind of preparation method of medicine-food two-purpose monomer, and in particular to it is high that one kind extracts preventing and treating from Semen Cuscutae
The preparation method of uricacidemia and gout medicine-food two-purpose monomer.
Background technology
The report of Chinese medicine hyperuricemia and primary gout is more.In clinical practice and daily life, people
Find that some can treat the effective single medicinal material of hyperuricemia, wherein the active component of many medicines and pharmacology are made
With being elucidated with.As Bi Collettii, the bark of ash, Bai Ai, globe artichoke, the root of Chinese clematis, plantain seed, golden cypress, desmodium, bark of ash etc. have certain
Anti-trioxypurine is acted on[1,2].Research display, barrenwort, coix seed, rhizoma alismatis, plantain seed, bark of ash can increase uric acid excretion, and bark of ash may be used also
Increase the dissolving of uric acid；Herba Lycopi, Radix Angelicae Sinensis can suppress uric acid synthesis.It is another to there is research to show that the bark of ash, Asiatic plantain, rheum officinale, rhizoma atractylodis promote
Uric acid is excluded from kidney, and rheum officinale energy uricosuric is excreted from stool；Lily, edible tulip etc. are acted on colchicinoid sample, can
Suppress leucocyte chemotaxis, so as to mitigate the inflammatory reaction of urarthritis；Waxgourd peel, the shell of areca nut, the root bark of white mulberry, dried orange peel, wood
The promoting the circulation of qi such as perfume, fuling peel profit water medicine can improve endogenous creatinine clearance rate, increase urine volume, discharge uric acid, reduce blood uric acid[3,4]。
Semen Cuscutae is convolvulaceous plant Cuscuta australis (Cuscuta australis R.Br.) or Semen Cuscutae (Cuscuta
Chinensis Lam.) dry mature seed, sweet, temperature returns kidney,liver,spleen to pass through, with nourishing liver and kidney, astringent sperm contracting urine, it is antiabortive,
The effect of improving eyesight, antidiarrheal.The main chemical compositions of Semen Cuscutae are resin-like glucoside, cholesterine, campesterol
(Campesterol), sitosterol, stigmasterol and triterpene acids, carbohydrate etc..Semen Cuscutae contains abundant chemical composition, in kidney tonifying
Establishing-Yang, improve immunocompetence, anti-aging, liver-nourishing and eyesight-improving, prevent miscarriage, adjust hypothalamic-pituitary-ovarian axis function, adjust endocrine,
Treatment angiocardiopathy, the aspects such as gonadal hormone sample effect that promote have extensive pharmacological action.Semen Cuscutae has contracting urine with anti-something lost
Urine is acted on, and enters kidney channel, " kidney governing water metabolism ", sweet kidney tonifying, and kidney qi is then taken the photograph effectively admittedly enough, makes bladder folding degree of having, and takes charge of urine drains；
Enter liver the spleen channel, aqueous that The spleen has the function to transport and transform nutrients, liver assists aqueous metabolism.Semen Cuscutae compound gives mouse stomach, can reduce urination amount and subtract
Few number of micturitions.
Treatment by Chinese herbs hyperuricemia and gout it is evident in efficacy, but Chinese medicine Shortcomings show several in use
Individual aspect：1st, conventional preparation and instructions of taking are inconvenient, such as decocting method, taste weight when taking, taking, and during because of personal decoction
Between it is different with decocting method, curative effect can not be completely secured；2nd, taking dose is big, decocts or directly crush the formulation for preparing, composition
Composition includes active principle and invalid component, and taking dose is big, it is impossible to reach the effect that Special Nursing in Special Disease is controlled, and is possible to produce poison
Side effect；3rd, monomeric compound low yield, high cost are obtained with modern separating and purifying technology, is difficult to realize scale and industry
Change；4th, realize that monomeric compound group still has certain technical difficulty, and high cost by modern synthetic technology.
[1] woods ultramarine, Xie Jian, king sea east ends extract solution to experimental study [J] of hyperuricemia rat China wind in vain
Diseases caused by dampness magazine, 2005,9 (8):509-510.
[2] Lin Fengping, appoints enlightenment, the root ofs Chinese clematis such as Song Enfeng to experimental study [J] Chinese patent drugs of UN rat,
2006,28(6):842-845.
[3] Lee's table, Sun Lin modern times Kidney Disease [M] Nanchang:In Jiangxi Science technology publishing house, 2000,537-
543.
[4] Shen Qing methods tcm clinical practices nephrology [M] Shanghai:Shanghai scientific and technical literature publishing house, 1998,206-
211.
The content of the invention
For the problem of above-mentioned Chinese medicine Shortcomings performance in use, the present invention provides that a kind of consumption is small, uses
Convenience, few adverse reaction, low cost, effect substantially, be easy to industrialized and prevent and treat hyperuricemia and gout medicine-food two-purpose monomer
Preparation method.
The purpose of the present invention will be achieved through the following technical solutions：One kind from Semen Cuscutae extract prevent and treat hyperuricemia and
The preparation method of gout medicine-food two-purpose monomer, comprises the following steps：
Step one, coarse extraction：After Semen Cuscutae raw material is smashed, the raw material of certain mass is weighed, add 20 times of 60% second of amount
After alcohol is heated to reflux 2h, the dregs of a decoction are isolated, 15 times of 60% ethanol of amount will be added to be heated to reflux 1.5h in the dregs of a decoction, merge extract solution,
High speed centrifugation, discards insoluble matter, and vacuum distillation ethanol obtains crude extract；
Step 2, chromatography：By AB-8 types macroporous resin column on crude extract in step one, Static Adsorption 2 hours,
10BV water elutions are used, eluent is discarded, then is eluted successively from low to high with different concentration ethanol, as extract solution；
Step 3, detection and analysis：Whether contain list during the extract solution in step 2 is differentiated into eluent with thin-layered chromatography
A certain monomer and its relative amount in body compound group, collect the eluent with accounting target compound high and merge, by institute
Obtain eluent and be prepared into product.
Preferably, described a kind of extraction from Semen Cuscutae prevents and treats the preparation of hyperuricemia and gout medicine-food two-purpose monomer
Method, in the step one, Semen Cuscutae includes Semen Cuscutae glycosides A, Semen Cuscutae glycosides B, new Semen Cuscutae glycosides A, new Semen Cuscutae glycosides B, new Tu
One or more in the sub- glycosides C of silk.
Preferably, described a kind of extraction from Semen Cuscutae prevents and treats the preparation of hyperuricemia and gout medicine-food two-purpose monomer
Method, in the step 3, the product of eluent processing includes capsule, tablet, mixture, food additives and health protection tea.
Preferably, described a kind of extraction from Semen Cuscutae prevents and treats the preparation of hyperuricemia and gout medicine-food two-purpose monomer
Method, the preparation method of the capsule is：Vacuum concentration, is vacuum dried or is spray-dried and to obtain fine powder, plus 6 times of 20% starch of amount
Paste, pelletizes encapsulated.
Preferably, described a kind of extraction from Semen Cuscutae prevents and treats the preparation of hyperuricemia and gout medicine-food two-purpose monomer
Method, the preparation method of the tablet is：Gained eluent is vacuum dried or is spray-dried to obtain fine powder, adds 6 times of amounts 20% to form sediment
Paste mixing, 1 times of amount 10%PVP (PVP) ethanol, granulation, drying, compressing tablet.
Preferably, described a kind of extraction from Semen Cuscutae prevents and treats the preparation of hyperuricemia and gout medicine-food two-purpose monomer
Method, the preparation method of the mixture is：Gained eluent concentrates or is diluted to the medicinal extract of relative density 1.2, and bottling makes mouth
Take liquid.
Preferably, described a kind of extraction from Semen Cuscutae prevents and treats the preparation of hyperuricemia and gout medicine-food two-purpose monomer
Method, the preparation method of the food additives is：Gained eluent is concentrated in vacuo, and is vacuum dried or is spray-dried and to obtain fine powder,
Can be used as food additives.
Preferably, described a kind of extraction from Semen Cuscutae prevents and treats the preparation of hyperuricemia and gout medicine-food two-purpose monomer
Method, the preparation method of the food additives is：The concentration of gained eluent is the medicinal extract of relative density 1.2, you can used as guarantor
Health food additive.
Preferably, described a kind of extraction from Semen Cuscutae prevents and treats the preparation of hyperuricemia and gout medicine-food two-purpose monomer
Method, the preparation method of the health protection tea is：Gained eluent is concentrated under reduced pressure into the medicinal extract of relative density 1.2, with extra-strong tea
Leaf presses 1：25 mass ratio mixing, dries 8 hours under the conditions of being placed in 55 DEG C, then is ground into 20 mesh, and sterilization packaging storage is made 6g
The anti-trioxypurine health protection tea of one bag.
The beneficial effects of the invention are as follows：Semen Cuscutae of the present invention contains phenylpropanoids, monomer of the present invention
It is made up of double parallel tetrahydrofuran ring connection glycosyls, such as n-butanol, ethyl acetate dissolubility are preferable in medium polar solvent, and
And with certain water solubility.The present invention is decocted using 60% ethanol and extracted, polar macroporous purifying resin, autotelic enrichment target
Monomeric compound group, low cost, high income easily realizes industrialization and scale.Capsule, tablet, guarantor prepared by the invention
Strong medicinal tea etc., convenient to takeization, with diversification feature.
Brief description of the drawings
Fig. 1 is the pathological anatomy figure of the blank group of the embodiment of the present invention 6；
Fig. 2 is the pathological anatomy figure of the model group of the embodiment of the present invention 6；
Fig. 3 is the pathological anatomy figure of the high dose group of the embodiment of the present invention 6.
Specific embodiment
To more fully understand the present invention, further specific elaboration is made to the present invention below by following examples, but not
Limitation of the invention is can be regarded as, it is nonessential according to some that foregoing invention content is made for those skilled in the art
Improve and adjust, be also considered as being within the scope of the present invention.
Embodiment 1, the preparation based on capsule of the present invention
1) bulk drug Semen Cuscutae is weighed, 3# hungry area softgel shells are some standby；
2) raw medicinal material adds 20 times of amount 60% ethanol cold soaking bubble 1d, heating and refluxing extraction 2h, the dregs of a decoction to add 15 times of 60% second of amount
Alcohol is heated to reflux 1.5h, merges extract solution, and ethanol is recovered under reduced pressure, and high speed centrifugation concentrate obtains filtrate, upper AB-8 types macropore tree
Fat post, Static Adsorption 2 hours, uses 10BV water elutions, discards eluent, then is eluted successively from low to high with different concentration ethanol,
With whether, containing a certain monomer and its relative amount in monomeric compound group, collection has high in thin-layered chromatography discriminating eluent
The eluent of accounting target compound simultaneously merges, and is vacuum dried or is spray-dried and to obtain fine powder, adds 6 times of 20% gelatinized corn starches of amount,
Granulation, drying loads 3# hungry area softgel shells, every content-filled about 0.32g of hungry area softgel shell, clean, select grain, is made appropriate packaging rule
The finished product of lattice.
Embodiment 2, the preparation based on Tablets
1) bulk drug Semen Cuscutae is weighed standby；
2) raw medicinal material adds 20 times of amount 60% ethanol cold soaking bubble 1d, heating and refluxing extraction 2h, the dregs of a decoction to add 15 times of 60% second of amount
Alcohol is heated to reflux 1.5h, merges extract solution, and ethanol is recovered under reduced pressure, and high speed centrifugation concentrate obtains filtrate, upper AB-8 types macropore tree
Fat post, Static Adsorption 2 hours, uses 10BV water elutions, discards eluent, then is eluted successively from low to high with different concentration ethanol,
With whether, containing a certain monomer and its relative amount in monomeric compound group, collection has high in thin-layered chromatography discriminating eluent
The eluent of accounting target compound simultaneously merges, and is vacuum dried or is spray-dried and to obtain fine powder, add 5 times of 20% gelatinized corn starches of amount, 1 times
Amount 10%PVP (PVP) ethanol, granulation, drying, the tabletted heavy for about former piece of 0.4g, sugar coating, chip select is made suitable
When the finished product of packing specification.
Embodiment 3, the preparation based on mixture of the present invention
1) bulk drug Semen Cuscutae is weighed, 10ml size oral liquid bottles and bottle cap are standby；
2) raw medicinal material adds 20 times of amount 60% ethanol cold soaking bubble 1d, heating and refluxing extraction 2h, the dregs of a decoction to add 15 times of 60% second of amount
Alcohol is heated to reflux 1.5h, merges extract solution, and ethanol is recovered under reduced pressure, and high speed centrifugation concentrate obtains filtrate, upper AB-8 types macropore tree
Fat post, Static Adsorption 2 hours, uses 10BV water elutions, discards eluent, then is eluted successively from low to high with different concentration ethanol,
With whether, containing a certain monomer and its relative amount in monomeric compound group, collection has high in thin-layered chromatography discriminating eluent
The eluent of accounting target compound simultaneously merges, and is concentrated into relative density 1.2, adds sweetener, preservative, fining agent etc., puts
Put, filter, take filtrate, sterilize, the filling oral liquid into 10ml/ branch rolls lid, is made the finished product of appropriate packing specification.
Embodiment 4, the preparation based on food supplement of the present invention
1) bulk drug Semen Cuscutae is weighed standby；
2) raw medicinal material adds 20 times of amount 60% ethanol cold soaking bubble 1d, heating and refluxing extraction 2h, the dregs of a decoction to add 15 times of 60% second of amount
Alcohol is heated to reflux 1.5h, merges extract solution, and ethanol is recovered under reduced pressure, and high speed centrifugation concentrate obtains filtrate, upper AB-8 types macropore tree
Fat post, Static Adsorption 2 hours, uses 10BV water elutions, discards eluent, then is eluted successively from low to high with different concentration ethanol,
With whether, containing a certain monomer and its relative amount in monomeric compound group, collection has high in thin-layered chromatography discriminating eluent
The eluent of accounting target compound simultaneously merges, and is concentrated into relative density 1.2, sterilizing, appropriate containers sealing, as health food
Additive；Or vacuum concentration, it is vacuum dried or is spray-dried and to obtain fine powder, appropriate containers sealing, as food supplement.
Embodiment 5, the preparation based on health protection tea of the present invention
1) bulk drug Semen Cuscutae is weighed, extra-strong tea is some standby；
2) raw medicinal material adds 20 times of amount 60% ethanol cold soaking bubble 1d, heating and refluxing extraction 2h, the dregs of a decoction to add 15 times of 60% second of amount
Alcohol is heated to reflux 1.5h, merges extract solution, and ethanol is recovered under reduced pressure, and high speed centrifugation concentrate obtains filtrate, upper AB-8 types macropore tree
Fat post, Static Adsorption 2 hours, uses 10BV water elutions, discards eluent, then is eluted successively from low to high with different concentration ethanol,
With whether, containing a certain monomer and its relative amount in monomeric compound group, collection has high in thin-layered chromatography discriminating eluent
The eluent of accounting target compound simultaneously merges, and is concentrated into relative density 1.2, and 1 is pressed with Tie Guanyin tea：25 mass ratioes mix,
Dried 8 hours under the conditions of being placed in 55 DEG C, then be ground into 20 mesh, sterilized, be made the anti-trioxypurine health protection tea of the bags of 6g mono-.
Embodiment 6, the present invention improve gouty nephropathy pathology
Experimental animal：KM mouse, SPF grades, male, body weight 18-22g is carried by Traditional Chinese Medicine University Of Guangzhou's Experimental Animal Center
For.Normal raising supplies examination after 3 days.
Medicine and reagent：Semen Cuscutae (Guangzhou Medicinal Material Co., Ltd. Traditional Chinese Medicinal Tablet Factory).
It is prepared by product of the present invention：Raw medicinal material Semen Cuscutae adds 20 times of amounts 60% ethanol cold soaking bubble 1d, heating and refluxing extraction 2h,
The dregs of a decoction add 15 times of 60% ethanol of amount to be heated to reflux 1.5h, merge extract solution, and ethanol is recovered under reduced pressure, and high speed centrifugation concentrate must be filtered
Liquid, upper AB-8 types macroporous resin column, Static Adsorption 2 hours uses 10BV water elutions, discards eluent, then use different concentration ethanol
Elute successively from low to high, whether a certain monomer and its phase in monomeric compound group are contained in differentiating eluent with thin-layered chromatography
To content, collect the eluent with accounting target compound high and merge, be vacuum dried or be spray-dried and to obtain fine powder, face use
Preceding distilled water is configured to required concentration.
KM mouse 80 are taken, four groups are equally divided into, fasting 10h before gavage prohibits water 6h.Daily gavage twice, every time
0.6ml, continuous 14 days, observes 14 days again after drug withdrawal.Blank group of the present invention：Give equivalent distilled water；Model group：Allopurinol
0.04g/kg/d is administered, high dose group：The product dosage is 6.00g/kg/d, equivalent to 3000 times of people's consumption.
Result of the test：(1) blank group (10)：As shown in Figure 1, cortex renis internal glomerulus is evenly distributed, under 10 times of object lens
Numbers of glomeruli is 15~20, and renal cells distribution is complete, and cast is had no in renal tubule tube chamber, and renal interstitial has no out
Blood, cell infiltration and urate crystal.(2) model group (10)：As shown in Figure 2, cortex renis numbers of glomeruli has been reduced,
Numbers of glomeruli is 5~10 under 10 times of object lens, and renal tubule stove shape atrophy is shown in protein cast in indivedual renal tubule tube chambers, has no
Uric acid mineralization, renal interstitial is shown in bleeding and Focal Lymphocytic Infiltration.(3) high dose group (10)：From the figure 3, it may be seen that glomerulus
Reduction degree, renal tubule atrophy are light compared with model group, and cast and urate crystal are had no in renal tubule tube chamber, and renal interstitial has no
Bleeding and lymphocytic infiltration.
Conclusion (of pressure testing)：The monomer of the present invention can improve gouty nephropathy
Embodiment 7, subchronic toxicity of the present invention experiment
Experimental animal：KM mouse, SPF grades, male, body weight 18-22g is carried by Traditional Chinese Medicine University Of Guangzhou's Experimental Animal Center
For.Normal raising supplies examination after 3 days.
Medicine and reagent：Semen Cuscutae (Guangzhou Medicinal Material Co., Ltd. Traditional Chinese Medicinal Tablet Factory).
It is prepared by product of the present invention：Raw medicinal material adds 20 times of amount 60% ethanol cold soaking bubble 1d, heating and refluxing extraction 2h, the dregs of a decoction to add
15 times of 60% ethanol of amount are heated to reflux 1.5h, merge extract solution, and ethanol is recovered under reduced pressure, and high speed centrifugation concentrate obtains filtrate, on
AB-8 type macroporous resin columns, Static Adsorption 2 hours, use 10BV water elutions, discard eluent, then with different concentration ethanol by as little as
Whether height is eluted successively, differentiates in eluent containing a certain monomer in monomeric compound group and its relative to contain with thin-layered chromatography
Amount, collects the eluent with accounting target compound high and merges, and is vacuum dried or is spray-dried and to obtain fine powder, before use with steaming
Distilled water is configured to required concentration.
KM mouse 80 are taken, four groups are equally divided into, fasting 10h before gavage prohibits water 6h.Daily gavage twice, every time
0.6ml, continuous 14 days, observes 14 days again after drug withdrawal.Medicine small dose group of the present invention：Dosage is 0.06g/kg/d, equivalent to people
30 times of consumption；Medicine middle dose group of the present invention：Dosage is 0.60g/kg/d, equivalent to 300 times of people's consumption；Medicine of the present invention is big
Dosage group：Dosage is 6.00g/kg/d, equivalent to 3000 times of people's consumption；Control group：Give equivalent distilled water.
Result of the test：Appetite is reduced in each group mouse species administration 5h, and activity weakens, medicine color semiliquid stool etc., extensive after drug withdrawal
It is multiple normal.Average weight of each test group when the 14th day after 14d being administered and being discontinued is compared with control group without significant difference (P>
0.05).Erythrocytes, total white blood cells, content of hemoglobin, the platelet count of test group mouse after drug withdrawal the 1st day and
After drug withdrawal the 14th day compared with control group without significant difference (P>0.05).The serum glutamic pyruvic transminase of each test group mouse, paddy
Careless transaminase, alkaline phosphatase after the drug withdrawal the 1st day and after being discontinued the 14th day compared with control group without significant difference (P>0.05).
The 1st day and the 14th day after drug withdrawal, cut open inspection is shown in that the form of each group heart, liver, spleen, lung, kidney, stomach and intestines, color, quality are normal.Disease
Reason histological examination.High, medium and low dosage group of the invention and control group mice are showed no obvious pathological change.
By experiment, high, medium and low dosage group of the invention is above clinical treatment dosage, is not found in the corresponding course for the treatment of
Any subchronic toxicity reaction.With reference to acute toxicity test, its consumption also has no that any poison is secondary equivalent to 3000 times of people's consumption
Reaction, therefore the present invention can be used as preventing and treating hyperuricemia, the dual-purpose formula of gout medicinal health food and preparation.
Conclusion (of pressure testing)：The subchronic toxicity test of the present invention shows safety non-toxic of the present invention.
Embodiment 8, acute toxicity test of the present invention
Experimental animal：KM mouse, SPF grades, male, body weight 18-22g is carried by Traditional Chinese Medicine University Of Guangzhou's Experimental Animal Center
For.Normal raising supplies examination after 3 days.
Medicine and reagent：Semen Cuscutae (Guangzhou Medicinal Material Co., Ltd. Traditional Chinese Medicinal Tablet Factory).
It is prepared by product of the present invention：Raw medicinal material adds 20 times of amount 60% ethanol cold soaking bubble 1d, heating and refluxing extraction 2h, the dregs of a decoction to add
15 times of 60% ethanol of amount are heated to reflux 1.5h, merge extract solution, and ethanol is recovered under reduced pressure, and high speed centrifugation concentrate obtains filtrate, on
AB-8 type macroporous resin columns, Static Adsorption 2 hours, use 10BV water elutions, discard eluent, then with different concentration ethanol by as little as
Whether height is eluted successively, differentiates in eluent containing a certain monomer in monomeric compound group and its relative to contain with thin-layered chromatography
Amount, collects the eluent with accounting target compound high and merges, and is vacuum dried or is spray-dried and to obtain fine powder, before use with steaming
Distilled water is configured to required concentration.
KM mouse 80 are taken, four groups are equally divided into, fasting 10h before gavage prohibits water 6h.Daily gavage twice, every time
0.6ml, continuous 7 days.Medicine small dose group of the present invention：Dosage is 0.06g/kg/d, equivalent to 30 times of people's consumption；Medicine of the present invention
Middle dose group：Dosage is 0.60g/kg/d, equivalent to 300 times of people's consumption；Drug bolus group of the present invention：Dosage is 6.00g/
Kg/d, equivalent to 3000 times of people's consumption；Control group：Give equivalent distilled water.
Result of the test：7 days mouse of experiment are all survived, and appetite is reduced in rarely seen animal administration 5h, and activity weakens, medicine color
Semiliquid stool etc., recovers normal after drug withdrawal.4 groups of animals drinking-water, hair color, body weight, excrement and the heart, liver, spleen, lung, kidney, thymus gland, brain,
The aspects such as form, size, the smoothness of main organs such as tongue, stomach, intestines, bladder, sexual gland (uterus, ovary or testis and epididymis) are
No significant difference.Described above, toxic and side effect of the present invention is small, and because by drug concentration and volumetric constraint, can not find and cause small
The dead dosage of mouse, therefore LD50 of the invention cannot be measured.
Experiment conclusion：The acute toxicity test of the present invention shows safety non-toxic of the present invention.
Presently preferred embodiments of the present invention is the foregoing is only, is not intended to limit the invention, it is all in essence of the invention
Within god and principle, any modification, equivalent substitution and improvements made etc. should be included within the scope of the present invention.
Claims (9)
1. a kind of that the preparation method for preventing and treating hyperuricemia and gout medicine-food two-purpose monomer is extracted from Semen Cuscutae, its feature exists
In comprising the following steps：
Step one, coarse extraction：After Semen Cuscutae raw material is smashed, the raw material of certain mass is weighed, add 20 times of 60% ethanol of amount to add
After heat backflow 2h, the dregs of a decoction are isolated, 15 times of 60% ethanol of amount will be added to be heated to reflux 1.5h in the dregs of a decoction, merge extract solution, at a high speed
Centrifugation, discards insoluble matter, and vacuum distillation ethanol obtains crude extract；
Step 2, chromatography：AB-8 types macroporous resin column on crude extract in step one, Static Adsorption 2 hours are used
10BV water elutions, discard eluent, then are eluted successively from low to high with different concentration ethanol, as extract solution；
Step 3, detection and analysis：Whether contain singulation during extract solution thin-layered chromatography in step 2 is differentiated into eluent
A certain monomer and its relative amount in compound group, collect the eluent with accounting target compound high and merge, and gained is washed
De- liquid is prepared into product.
2. a kind of extraction from Semen Cuscutae according to claim 1 prevents and treats hyperuricemia and gout medicine-food two-purpose monomer
Preparation method, it is characterised in that：In the step one, Semen Cuscutae includes Semen Cuscutae glycosides A, Semen Cuscutae glycosides B, new Semen Cuscutae glycosides A, new
One or more in Semen Cuscutae glycosides B, new Semen Cuscutae glycosides C.
3. a kind of extraction from Semen Cuscutae according to claim 1 prevents and treats hyperuricemia and gout medicine-food two-purpose monomer
Preparation method, it is characterised in that：In the step 3, the product of eluent processing includes capsule, tablet, mixture, food additive
Plus agent and health protection tea.
4. a kind of extraction from Semen Cuscutae according to claim 3 prevents and treats hyperuricemia and gout medicine-food two-purpose monomer
Preparation method, it is characterised in that the preparation method of the capsule is：Fine powder is concentrated in vacuo, is vacuum dried or is spray-dried and to obtain,
Plus 6 times of 20% gelatinized corn starches of amount, pelletize encapsulated.
5. a kind of extraction from Semen Cuscutae according to claim 3 prevents and treats hyperuricemia and gout medicine-food two-purpose monomer
Preparation method, it is characterised in that the preparation method of the tablet is：Gained eluent is vacuum dried or is spray-dried to obtain fine powder,
Add 6 times of 20% gelatinized corn starches of amount, 1 times of amount 10%PVP (PVP) ethanol, granulation, drying, compressing tablet.
6. a kind of extraction from Semen Cuscutae according to claim 3 prevents and treats hyperuricemia and gout medicine-food two-purpose monomer
Preparation method, it is characterised in that the preparation method of the mixture is：Gained eluent concentrates or is diluted to relative density 1.2
Medicinal extract, bottling makes oral liquid.
7. a kind of extraction from Semen Cuscutae according to claim 3 prevents and treats hyperuricemia and gout medicine-food two-purpose monomer
Preparation method, it is characterised in that the preparation method of the food additives is：Gained eluent be concentrated in vacuo, vacuum drying or
It is spray-dried to obtain fine powder, you can as food additives.
8. a kind of extraction from Semen Cuscutae according to claim 3 prevents and treats hyperuricemia and gout medicine-food two-purpose monomer
Preparation method, it is characterised in that the preparation method of the food additives is：The concentration of gained eluent is relative density 1.2
Medicinal extract, you can as food additives.
9. a kind of extraction from Semen Cuscutae according to claim 3 prevents and treats hyperuricemia and gout medicine-food two-purpose monomer
Preparation method, it is characterised in that the preparation method of the health protection tea is：Gained eluent is concentrated under reduced pressure into relative density 1.2
Medicinal extract, 1 is pressed with Tie Guanyin tea：25 mass ratio mixing, dries 8 hours under the conditions of being placed in 55 DEG C, then is ground into 20 mesh, sterilizes
Packaging and storage, is made the anti-trioxypurine health protection tea of the bags of 6g mono-.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610996958.XA CN106727857A (en) | 2016-11-14 | 2016-11-14 | It is a kind of that the preparation method for preventing and treating hyperuricemia and gout medicine-food two-purpose monomer is extracted from Semen Cuscutae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610996958.XA CN106727857A (en) | 2016-11-14 | 2016-11-14 | It is a kind of that the preparation method for preventing and treating hyperuricemia and gout medicine-food two-purpose monomer is extracted from Semen Cuscutae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106727857A true CN106727857A (en) | 2017-05-31 |
Family
ID=58973455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610996958.XA Pending CN106727857A (en) | 2016-11-14 | 2016-11-14 | It is a kind of that the preparation method for preventing and treating hyperuricemia and gout medicine-food two-purpose monomer is extracted from Semen Cuscutae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106727857A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107495378A (en) * | 2017-10-13 | 2017-12-22 | 武汉华康臣生物科技有限公司 | A kind of functional food suitable for gout and people with high uric acid |
| CN108721538A (en) * | 2017-08-23 | 2018-11-02 | 极原国际健康管理服务有限公司 | A kind of drink prevented or treat hyperuricemia and gout |
| CN114949069A (en) * | 2022-06-29 | 2022-08-30 | 劲牌有限公司 | Uric acid-reducing traditional Chinese medicine composition for inhibiting xanthine oxidase and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895320A (en) * | 2012-04-16 | 2013-01-30 | 全金花 | Medicinal food formula and medicinal edible preparation for preventing and treating hyperuricemia and gout |
| KR20130136151A (en) * | 2012-06-04 | 2013-12-12 | 권태선 | Improving gout, reducing uric acid, solving hangover of functional fermented food and method for producing of the same, and kimchi, gochujang, doenjang, soy sauce produced thereof |
-
2016
- 2016-11-14 CN CN201610996958.XA patent/CN106727857A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895320A (en) * | 2012-04-16 | 2013-01-30 | 全金花 | Medicinal food formula and medicinal edible preparation for preventing and treating hyperuricemia and gout |
| KR20130136151A (en) * | 2012-06-04 | 2013-12-12 | 권태선 | Improving gout, reducing uric acid, solving hangover of functional fermented food and method for producing of the same, and kimchi, gochujang, doenjang, soy sauce produced thereof |
Non-Patent Citations (6)
| Title |
|---|
| X. LING ET AL.: "A review of phytotherapy of gout:perspective of new pharmacological treatments", 《PHARMAZIE》 * |
| 山东省食品药品监督管理局: "《山东省中药饮片炮制规范》", 31 January 2013, 山东科学技术出版社 * |
| 张晶等: "《中药化学》", 30 April 2015, 中国农业大学出版社 * |
| 汪茂田等: "《天然有机化合物提取分离与结构鉴定》", 30 September 2004, 化学工业出版社 * |
| 范江华等: "痛风发生因素分析与预防对策", 《中国医学创新》 * |
| 郭澄等: "菟丝子的化学成分和药理活性研究", 《时珍国医国药》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108721538A (en) * | 2017-08-23 | 2018-11-02 | 极原国际健康管理服务有限公司 | A kind of drink prevented or treat hyperuricemia and gout |
| CN107495378A (en) * | 2017-10-13 | 2017-12-22 | 武汉华康臣生物科技有限公司 | A kind of functional food suitable for gout and people with high uric acid |
| CN114949069A (en) * | 2022-06-29 | 2022-08-30 | 劲牌有限公司 | Uric acid-reducing traditional Chinese medicine composition for inhibiting xanthine oxidase and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007009291A1 (en) | A pharmaceutical composition of traditional chineses medicine for treating rheumatoid arthritis and preparation thereof | |
| CN102370687B (en) | A kind of compound Chinese medicinal preparation for treating colitis and preparation method thereof | |
| CN103585400B (en) | Have and strengthen immunologic function and the compositions alleviating fatigue effect and preparation method thereof | |
| CN102397372A (en) | Medicinal composition and pharmaceutical preparation and application thereof to treating irritable bowel syndrome | |
| CN106727857A (en) | It is a kind of that the preparation method for preventing and treating hyperuricemia and gout medicine-food two-purpose monomer is extracted from Semen Cuscutae | |
| CN102961596B (en) | Traditional Chinese medicine composition for treating diabetes as well as preparation method and application of for traditional Chinese medicine composition | |
| CN1935194B (en) | Preparation method of Chinese medicine composition for treating nephroma | |
| CN102266503B (en) | Sugar-free anemopyretic cold granules and preparation method thereof | |
| CN104013733B (en) | Chitosan composition for prevention and treatment of chemical liver injury and preparation method thereof | |
| WO2013155995A1 (en) | Red yeast and kudzu root pharmaceutical composition for regulating blood lipids and preparation method therefor | |
| CN102228551B (en) | Chinese medicinal composition for preventing and treating injury of gastric mucosa and preparation method thereof | |
| CN108721431B (en) | Traditional Chinese medicine composition for removing heavy metals and application thereof | |
| CN102133273B (en) | Traditional Chinese medicine lipid-lowing and catharsis capsule and preparation method thereof | |
| CN104013764A (en) | Traditional Chinese medicine with immunity enhancing function and preparation method thereof | |
| CN111110735A (en) | Lipid-lowering pharmaceutical composition, preparation method and application | |
| CN110876772A (en) | Preparation method and application of traditional Chinese medicine preparation with liver protection function | |
| CN101683429A (en) | Animal Chinese medicine granular formulation for preventing and treating infectious bursal disease of fowl and preparation method thereof | |
| CN113876896A (en) | Three-rice-drink traditional Chinese medicine formula composition for reducing uric acid and relieving gout and preparation process thereof | |
| CN102204985A (en) | Compound lychee seed hpyerglycemic particles and preparation method thereof | |
| CN105748628A (en) | Traditional Chinese medicine soluble powder for treating piglet diarrhea | |
| CN106377651A (en) | Preparation method for extracting pharmaceutical monomer for preventing and treating hyperuricemia and gout from rhizoma smilacis glabrae | |
| CN106581352A (en) | Blood pressure lowering medicine and production method thereof | |
| US7179492B2 (en) | Traditional chinese pharmaceutical formulation for treatment of paradentosis&comma; process for preparation and use thereof | |
| CN106728137A (en) | It is a kind of that the preparation method for preventing and treating hyperuricemia and gout medicine-food two-purpose monomer is extracted from coffee | |
| CN104857143A (en) | Medicinal preparation for improving anoxia endurance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20170804 Address after: 510000 Tianhe District, Guangdong, No. five road, No. 381, Applicant after: Zhang Qingzhong Address before: Wushan Technology Plaza 373 No. 510000 Guangdong province Guangzhou city Tianhe District road five Applicant before: Guangzhou carpenter Technology Co., Ltd. |
|
| TA01 | Transfer of patent application right | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |
|
| RJ01 | Rejection of invention patent application after publication |